@misc{indiciae03cb6f606ea3,
  title = {A phase II study to evaluate the efficacy of commercially available molecularly matched targeted therapies in the second-line setting.},
  author = {Suzanne Jones and Gerald Falchook and Stephanie Graff and Edward Arrowsmith and Deepak Kilari and Todd A Gersten and Maen Hussein and Ivor Percent and Howard A Burris},
  year = {2026},
  doi = {10.1093/oncolo/oyag279},
  url = {https://pubmed.ncbi.nlm.nih.gov/42485262/},
  note = {Source identifier: 42485262}
}